SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RIZZI, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.222
AS - Asia 5.325
EU - Europa 3.163
SA - Sud America 731
AF - Africa 109
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 20.563
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.024
SG - Singapore 2.082
CN - Cina 1.395
DE - Germania 839
VN - Vietnam 615
BR - Brasile 568
UA - Ucraina 518
GB - Regno Unito 382
HK - Hong Kong 362
IT - Italia 357
FI - Finlandia 340
TR - Turchia 327
FR - Francia 185
RU - Federazione Russa 137
IN - India 119
SE - Svezia 115
JP - Giappone 113
CA - Canada 107
BD - Bangladesh 70
MX - Messico 68
PL - Polonia 65
AR - Argentina 46
ZA - Sudafrica 46
NL - Olanda 45
IQ - Iraq 40
BE - Belgio 39
ES - Italia 34
PK - Pakistan 31
LT - Lituania 28
CO - Colombia 26
ID - Indonesia 26
EC - Ecuador 25
UZ - Uzbekistan 21
VE - Venezuela 20
SA - Arabia Saudita 19
MA - Marocco 18
AE - Emirati Arabi Uniti 16
CZ - Repubblica Ceca 16
MY - Malesia 12
PH - Filippine 12
PY - Paraguay 12
CL - Cile 11
TN - Tunisia 11
AT - Austria 9
NP - Nepal 9
PE - Perù 9
UY - Uruguay 9
AU - Australia 8
EG - Egitto 8
IL - Israele 8
CH - Svizzera 7
IR - Iran 7
JO - Giordania 7
DO - Repubblica Dominicana 6
IE - Irlanda 6
KE - Kenya 6
BG - Bulgaria 5
BO - Bolivia 5
GR - Grecia 5
KR - Corea 5
RO - Romania 5
AL - Albania 4
ET - Etiopia 4
HR - Croazia 4
KZ - Kazakistan 4
SN - Senegal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
BH - Bahrain 3
CR - Costa Rica 3
DZ - Algeria 3
JM - Giamaica 3
LB - Libano 3
NO - Norvegia 3
SV - El Salvador 3
TH - Thailandia 3
BB - Barbados 2
BJ - Benin 2
CY - Cipro 2
DK - Danimarca 2
HN - Honduras 2
KH - Cambogia 2
LK - Sri Lanka 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
AM - Armenia 1
BF - Burkina Faso 1
BY - Bielorussia 1
CG - Congo 1
CV - Capo Verde 1
GA - Gabon 1
GE - Georgia 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 20.552
Salva come PNG Salva come JPEG
Città #
Singapore 1.400
Ashburn 1.295
Fairfield 1.156
Woodbridge 1.108
Houston 671
San Jose 598
Jacksonville 577
Ann Arbor 564
Chandler 513
Seattle 443
Beijing 440
Santa Clara 422
Wilmington 411
Cambridge 379
Hong Kong 357
Munich 340
Ho Chi Minh City 204
Izmir 185
Los Angeles 176
Helsinki 155
Nanjing 154
New York 154
Dallas 138
Hanoi 133
Milan 118
Princeton 113
Tokyo 111
San Diego 102
Boardman 100
Lauterbourg 97
Shanghai 90
São Paulo 72
Turku 72
Ferrara 61
Nanchang 61
Orem 58
Warsaw 55
Dearborn 54
London 54
Shenyang 47
Frankfurt am Main 46
Mexico City 38
Brussels 37
Denver 35
Hebei 35
Bremen 34
Brooklyn 33
Falkenstein 33
Buffalo 32
Tianjin 32
Atlanta 31
Da Nang 29
Hefei 29
Chennai 28
Chicago 28
Montreal 28
Toronto 28
Johannesburg 27
Auburn Hills 25
Haiphong 25
Jiaxing 24
Mountain View 24
San Mateo 24
Manchester 23
Rio de Janeiro 23
Falls Church 22
Mcallen 22
Stockholm 22
The Dalles 22
Norwalk 21
Dhaka 20
Tashkent 20
Amsterdam 19
Boston 19
Changsha 19
Mumbai 19
Baghdad 18
Jinan 18
Philadelphia 18
Phoenix 18
Bologna 17
Montréal 17
Moscow 17
Zhengzhou 17
Addison 16
Poplar 16
San Francisco 16
Redwood City 15
Kunming 14
Lahore 14
Guangzhou 13
Jeddah 13
Tappahannock 13
Hải Dương 12
Indiana 12
Belo Horizonte 11
Biên Hòa 11
Curitiba 11
Ankara 10
New Delhi 10
Totale 14.561
Salva come PNG Salva come JPEG
Nome #
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 391
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 307
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 286
A new selective antagonist of the nociceptin receptor 269
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 269
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 265
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 259
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 257
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 257
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 253
A new ligand for the urotensin II receptor 252
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 251
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 244
Ala scan analogues of HOE 140. Synthesis and biological activities 237
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 237
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 234
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 233
Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies 229
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 227
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 226
Effects of vasoactive agents in healthy and diseased human saphenous veins 226
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 222
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 218
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 217
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 216
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 212
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 212
Pharmacological characterization of tachykinin tetrabranched derivatives 212
Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test 211
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 210
B1 and B2 kinin receptors in various species 209
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 209
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 209
Pharmacological characterisation of novel kinin B2 receptor ligands 206
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 206
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 206
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 204
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 204
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 204
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 203
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 201
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 201
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 200
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 198
Pharmacological characterization of nociceptin receptor: an in vitro study 198
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 196
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 196
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 196
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 195
Structure-activity study at positions 3 and 4 of human neuropeptide S. 194
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 193
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 193
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 188
Anxiolytic-like effect of neuropeptide S in the rat defensive burying 184
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 184
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 183
Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors) 182
Characterization of the human vascular kinin B2 receptor by binding assays. 180
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 176
Pharmacological characterisation of the first non-peptide bradykinin B2 receptor agonist FR 190997: An in vitro study on human, rabbit and pig vascular B2 receptors 176
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 175
In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist 173
Nociceptin/orphanin FQ receptor ligands 172
Structure-activity relationship study on human urotensin II 172
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist 171
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 169
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 168
Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A 165
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 164
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 164
Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys 162
Pharmacology of nociceptin and its receptor: a novel therapeutic target 160
Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor 160
Nociceptin receptor binding in mouse forebrain membranes: Thermodynamic characteristics and structure activity relationships 159
Characterization of endothelin receptors in the human umbilical artery and vein 159
In vitro pharmacological profile of peptide III-BTD: A novel ligand for nociceptin/orphanin FQ and opioid receptors 158
The mouse vas deferens: A pharmacological preparation sensitive to nociceptin 157
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor 156
Pharmacology of the Kallikrein-Kinin system 156
Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery 154
In vitro characterization of FR 190997, the first non peptide B2 receptor agonist receptor binding and bioassay in the human umbilical vein 154
In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol 154
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH2: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor 152
Receptors for kinins in the human isolated umbilical vein 151
Effects of Ro 64-6198 it nociceptin/orphanin FQ-sensitive isolated tissues 151
Endogenous nociceptin signaling and stress-induced analgesia 148
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes 148
Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors 143
FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study 140
Further studies on nociceptin related peptides: discovery of new molecules with antagonist activity on the nociceptin receptor 139
Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities 138
In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative 138
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes. 136
Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad? 132
Further studies on nociceptin/orphanin FQ related peptides: discovery of a new chemical template with antagonist activity on the OP4 receptor. 131
Pharmacological characterization of the nociceptin receptors in the mouse: receptor binding, bioassay and behavioral studies 131
Pharmacology of [tyr1]nociceptin analogs: receptor binding and bioassay studies 128
Characterization of the human vascular kinin B2 receptor by binding assays 126
MEN 11270, a novel selective constrained peptide antagonist with high affinity at the human B-2 kinin receptor 117
null 110
Totale 19.254
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.939
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021427 0 0 0 0 0 0 0 0 0 171 188 68
2021/20221.209 45 117 98 81 65 48 64 80 50 104 112 345
2022/20231.252 119 58 58 162 211 169 97 106 162 5 61 44
2023/2024646 73 82 30 16 35 131 24 57 9 12 21 156
2024/20252.838 67 70 209 108 326 315 126 171 418 239 430 359
2025/20267.076 849 329 619 1.013 1.132 476 892 377 707 682 0 0
Totale 20.663